Campbell & Co. Investment Adviser »

Kalvista Pharmaceuticals shares owned by Campbell & Co. Investment Adviser

Quarter-by-quarter ownership of Kalvista Pharmaceuticals (KALV) shares owned by Campbell & Co. Investment Adviser from 13F filings

Historical chart of Campbell & Co. Investment Adviser investment in Kalvista Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Kalvista Pharmaceuticals held by Campbell & Co. Investment Adviser consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kalvista Pharmaceuticals by Campbell & Co. Investment Adviser

Quarter filed Position value Share count Share price at filing
2026-03-31 $1.3M 64k 20.13
2024-03-31 $119k 10k 11.86

More positions owned by Campbell & Co. Investment Adviser

Bank of Nova Scotia/The Common Stock (BNS)
Shell Adr (SHEL)
Illinois Tool Works Common Stock (ITW)
Williams Cos Inc/The Common Stock (WMB)
Alphabet Common Stock (GOOGL)
Phillips 66 Common Stock (PSX)
Murphy Oil Corp Common Stock (MUR)
Teledyne Technologies Common Stock (TDY)
Nordson Corp Common Stock (NDSN)
Agilent Technologies Common Stock (A)
EQT Corp Common Stock (EQT)
Expand Energy Corp Common Stock (EXE)
Atmos Energy Corp Common Stock (ATO)
Chevron Corp Common Stock (CVX)
Baker Hughes Common Stock (BKR)

View all positions for Campbell & Co. Investment Adviser

Top funds holding Kalvista Pharmaceuticals

VR Adviser
Frazier Life Sciences Management
Suvretta Capital Management
Tang Capital Management
BlackRock
Silverarc Capital Management
Capital World Investors
Vanguard Group
Caption Management
Point72 Asset Management
State Street Corporation
Millennium Management
Vestal Point Capital
Parkman Healthcare Partners
Vanguard Capital Management

View all funds holding Kalvista Pharmaceuticals